180 related articles for article (PubMed ID: 8882596)
21. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.
Wileman SM; Mann GE; Baydoun AR
Br J Pharmacol; 1995 Dec; 116(8):3243-50. PubMed ID: 8719803
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ornithine decarboxylase potentiates nitric oxide production in LPS-activated J774 cells.
Baydoun AR; Morgan DM
Br J Pharmacol; 1998 Dec; 125(7):1511-6. PubMed ID: 9884080
[TBL] [Abstract][Full Text] [Related]
25. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta.
Wylam ME; Metkus AP; Umans JG
Life Sci; 2001 Jun; 69(4):455-67. PubMed ID: 11459436
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.
Hirokawa K; O'Shaughnessy KM; Ramrakha P; Wilkins MR
Br J Pharmacol; 1994 Dec; 113(4):1448-54. PubMed ID: 7534188
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages.
Kengatharan M; De Kimpe SJ; Thiemermann C
Br J Pharmacol; 1996 Mar; 117(6):1163-70. PubMed ID: 8882611
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
Dusting GJ; Akita K; Hickey H; Smith M; Gurevich V
Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443
[TBL] [Abstract][Full Text] [Related]
31. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
32. Effect of swimming on vascular reactivity to phenylephrine and KC1 in male rats.
Jansakul C
Br J Pharmacol; 1995 Jun; 115(4):587-94. PubMed ID: 7582476
[TBL] [Abstract][Full Text] [Related]
33. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Thiemermann C; Ruetten H; Wu CC; Vane JR
Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase.
Ruetten H; Southan GJ; Abate A; Thiemermann C
Br J Pharmacol; 1996 May; 118(2):261-70. PubMed ID: 8735625
[TBL] [Abstract][Full Text] [Related]
35. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.
Thiemermann C; Wu CC; Szabó C; Perretti M; Vane JR
Br J Pharmacol; 1993 Sep; 110(1):177-82. PubMed ID: 7693276
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cells.
Paul A; Bryant C; Lawson MF; Chilvers ER; Plevin R
Br J Pharmacol; 1997 Apr; 120(8):1439-44. PubMed ID: 9113363
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by N-acetyl-5-hydroxytryptamine of nitric oxide synthase expression in cultured cells and in the anaesthetized rat.
Klemm P; Hecker M; Stockhausen H; Wu CC; Thiemermann C
Br J Pharmacol; 1995 Aug; 115(7):1175-81. PubMed ID: 7582541
[TBL] [Abstract][Full Text] [Related]
38. Cloricromene inhibits the induction of nitric oxide synthase.
Zingarelli B; Carnuccio R; Di Rosa M
Eur J Pharmacol; 1993 Oct; 243(2):107-11. PubMed ID: 7506214
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
Zhou J; Struthers AD; Lyles GA
Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
